YOUR SEARCH FOR Text 260 RESULTS
249 of Total
Incyte Announces Change to its Board of Directors | Incyte
View all news Incyte Announces Change to its Board of Directors December 12, 2025 at 8:30 AM EST PDF Version WILMINGTON, Del. --(BUSINESS WIRE)--Dec
250 of Total
Incyte Announces European Commission Approval of Minjuvi® (tafasitamab) for the Treatment of Relapse
View all news Incyte Announces European Commission Approval of Minjuvi® (tafasitamab) for the Treatment of Relapsed or Refractory Follicular Lymphoma